BENEŠ, Petr, Jan MUŽÍK, Jaroslav BENEDÍK, Lubomír ELBL, Vladimír ZNOJIL and Jiří VÁCHA. Apolipoprotein B signal peptide polymorphism in relation to lipids and diabetes in male CAD patients. Atherosclerosis. Irsko: ELSEVIER SCI IRELAND LTD, 2000, vol. 152, No 1, p. 257-258. ISSN 0021-9150.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Apolipoprotein B signal peptide polymorphism in relation to lipids and diabetes in male CAD patients
Authors BENEŠ, Petr, Jan MUŽÍK, Jaroslav BENEDÍK, Lubomír ELBL, Vladimír ZNOJIL and Jiří VÁCHA.
Edition Atherosclerosis, Irsko, ELSEVIER SCI IRELAND LTD, 2000, 0021-9150.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.386
RIV identification code RIV/00216224:14110/00:00002446
Organization unit Faculty of Medicine
UT WoS 000089447700030
Keywords in English apolipoprotein B; polymorphism; coronary artery disease; type 2 diabetes mellitus; lipoproteins
Tags apolipoprotein B, coronary artery disease, lipoproteins, polymorphism, type 2 diabetes mellitus
Changed by Changed by: RNDr. Jan Mužík, Ph.D., učo 1574. Changed: 17/4/2001 10:25.
Abstract
Our findings show that the apo B Ins/Del polymorphism affects plasma lipoprotein and apolipoprotein levels in male CAD patients and that the Ins allele is associated with the type II diabetes mellitus in these patients with a marginal significance.
Links
MSM 141100002, plan (intention)Name: Molekulární patofyziologie multigenních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of multigene diseases
VS96097, research and development projectName: Molekulární patofyziologie vybraných "civilizačních", multigenně podmíněných chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of selected multigenic related to civilization diseases
PrintDisplayed: 30/4/2024 18:57